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ABSTRACT OF THESIS 
COGNITION, REPETITIVE THOUGHT, AND SYSTEMIC INFLAMMATION 
IN THE MIDLIFE IN THE UNITED STATES STUDY 
Segerstrom et al. (2017) found that more repetitive thought (RT) was related to 
lower interleukin-6 (IL-6), in older adults at average IQ. This study aimed to replicate 
and extend this finding in midlife adults, with a daily measure of RT, and additional 
inflammatory biomarkers. 153 participants were drawn from the Midlife in the United 
States (MIDUS) Refresher project; ages 25-70 (M = 45.07, SD = 10.96), 50.3% female, 
and 83% Caucasian. Cognition was assessed via the Brief Test of Adult Cognition by 
Telephone, biological data via fasted blood draw, and RT data were collected as part of 
the National Study of Daily Experiences daily diary. Total RT (amount one engages in 
RT) and RT valence (positive vs. negative thought content) were analyzed. As IQ 
increased, more positive RT was associated with lover levels of IL-6 and CRP after 
adjusting for age, BMI, and statin use (b = -.161, p = .029; b = -.240, p = .002). Results 
did not replicate Segerstrom et al. (2017) but suggested that crystallized intelligence and 
RT total reflect a cognitive system different than that of fluid intelligence, executive 
functioning, and RT valence. Future studies should continue to investigate effects of RT 
on health outcomes.  
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CHAPTER ONE: INTRODUCTION 
Poor cognitive abilities may contribute to higher risk of smoking, being obese, 
higher blood pressure, higher risk for psychiatric disorders, less success in managing 
health behaviors, and higher levels of mortality in adults aged 60 years or older (Batty, 
Deary, & Macintyre, 2007; Batty, Deary, Schoon, & Gale, 2007a; Deary, Weiss, & Batty, 
2010; Sachs et al., 2011). Cognition and intelligence may also contribute to higher levels 
of systemic inflammation, which can influence the development of chronic diseases and 
increase one’s risk for stroke, heart attack, and mortality (Franceschi et al., 2000; Harris 
et al., 1999; Newman et al., 2009; Segerstrom, Reed, & Scott, 2017).  
Segerstrom, Reed, and Scott (2017) investigated the relationship between 
intelligence and systemic inflammation, measured using interleukin-6 (IL-6), a pro-
inflammatory cytokine. Specifically, they explored the role that repetitive thought (RT) 
may have in this established relationship. The 120-participant, longitudinal study of older 
adults (Mage = 74 years, MIQ = 113), initially found that higher IQ predicted lower levels 
of IL-6 and that the total amount that one engages in RT (total RT) mediated this 
relationship. However, they also found that the amount one engaged in RT did not predict 
systemic inflammation in individuals with high IQ, but that more engagement in RT did 
predict lower levels of systemic inflammation in individuals with an average IQ; thus, IQ 
also moderated the relationship between total RT and systemic inflammation.  
A replication of this finding could corroborate the results and expand upon what 
was found using a larger, more diverse sample with additional markers of systemic 
inflammation. Segerstrom and colleagues (2017) studied an aging population with a high 
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mean IQ (M = 113); a replication study focusing on a larger age range and closer-to-
average IQ would increase generalizability. 
In addition, Segerstrom and colleagues (2017) measured RT at the trait level, 
which provided a limited picture of day-to-day RT and its potential effects. Although 
collecting data on RT at the trait level is convenient, there are risks associated with 
measuring any construct retrospectively, including the biases that may skew one’s 
memory and reporting of such events or feelings (Brown & Harris, 1978; Thompson, 
Skowronski, Larsen, & Betz, 2013). Additionally, there is evidence of lack of 
correspondence between retrospective and daily diary data collection. Stone and 
colleagues (1998) found that 30% of participants were not able to accurately recall what 
they had endorsed previously on ecological momentary assessments of coping. A daily 
measure of RT would provide a different, and potentially more accurate, representation of 
daily RT for each participant. 
Lastly, Segerstrom and colleagues (2017) operationalized systemic inflammation 
as serum IL-6. Additional pro-inflammatory biomarkers would provide a more 
comprehensive understanding regarding the role of IQ and RT on systemic inflammation.  
The aim of this study was to replicate the findings of Segerstrom and colleagues 
(2017), that IQ moderates the relationship between RT and systemic inflammation, in a 
sample of larger age range, closer-to-average IQ range, and with additional pro-
inflammatory biomarkers: C-reactive protein (CRP) and tumor necrosis factor alpha 
(TNF-a). 
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Systemic Inflammation and Cognition 
Inflammation can be an acute and beneficial immune response to sites of injury, 
invasion, or infection (Segerstrom & Miller, 2004). However, under situations of stress, 
aging, or illness, systemic levels of inflammation can increase, leading to possible tissue 
damage, degeneration, and dysfunction of the immune system (Franceschi et al., 2000; 
Franceschi & Campisi, 2014; Segerstrom & Miller, 2004). Individuals whose bodies 
remain at low-grade, chronic states of inflammation may be at higher risk for negative 
health consequences such as schizophrenia, Parkinson’s disease, Alzheimer’s disease, 
and multiple sclerosis, and older individuals may be at a higher risk of morbidity and 
mortality (Franceschi et al., 2000; Stolp & Dziegielewska, 2009).  
IL-6, CRP, and TNF-a are commonly studied inflammatory biomarkers because 
they are easy to detect, easy to study, and sufficiently studied in prior literature 
(Franceschi & Campisi, 2014; Michaud et al., 2013). IL-6, a primarily pro-inflammatory 
cytokine involved in specific and nonspecific immune responses, can be induced by 
TNF-a, a pro-inflammatory cytokine also found in the central nervous system that works 
to induce other cytokines to sites of injury or infection (Ershler & Keller, 2000; see 
reviews by Hopkins & Rothwell, 1995; Rothwell & Hopkins, 1995; Yudkin et al., 2000). 
IL-6 and TNF-a can regulate the synthesis of CRP, part of the innate immune system 
involved in cell death and inducing cytokines to sites of injury and infection (Gabay & 
Kushner, 1999; see review by Yudkin et al., 2000).  
Systemic inflammation may be predicted and affected by cognitive deficits and 
decline. Decline of global cognition and executive function were related to elevated 
levels of IL-6 and CRP (IL-6, r = 0.56; CRP, r = 0.53, and IL-6, r = 0.54; CRP, r = 0.54, 
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respectively), even after adjusting for socioeconomic status, depression, and other clinical 
conditions (Kuo et al., 2005; Schram et al., 2007; Tegeler et al., 2016). In 500 middle-
aged adults, worse short-term memory, verbal and mathematical reasoning, vocabulary, 
and verbal fluency were related to higher IL-6; after controlling for age, gender, race, and 
education, poorer performance on auditory recognition tasks (b = 0.12, r = 0.13) and 
working memory (b = 0.13, r = 0.14) remained significantly related to elevated levels of 
IL-6 (Marsland et al., 2006). A similar relationship was found for CRP: decline in 
vocabulary with age, poorer performance on tasks of short-term memory, verbal fluency, 
verbal and mathematical reasoning, and vocabulary were related to elevated levels of 
CRP in older males, with the latter two remaining significant in the adjusted model (OR = 
1.38 and OR = 1.52) (Gimeno, Marmot, & Singh-Manoux, 2008). In a longitudinal study 
with 1,352 participants, poorer visual organization (b = -0.06) and Boston Naming Test 
performance (b = -0.02) (Jefferson et al., 2011) was related to higher CRP. Further, 
poorer reading performance after 6.3 years (b = -0.68), as well as visual organization (b 
= -0.11), visual attention and task switching (b = 0.04), and similarities (b = -0.08) were 
related to higher levels of TNF-a at baseline (Jefferson et al., 2011). Increased rate of 
cognitive decline in individuals with Alzheimer’s disease and in healthy adults may also 
be associated with higher levels of TNF-a (Bruunsgaard et al., 1999; Holmes et al., 
2009). Studying cognition and immune function across the lifespan is important for a 
comprehensive understanding of how the mind effects the body (Batty, Deary, & 
Macintyre, 2007; Batty, Deary, Schoon, Gale, 2007; Calvin, Batty, Lowe, & Deary, 
2011). 
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Repetitive Thought 
RT is defined as the “process of thinking attentively, repetitively, or frequently 
about oneself and one’s world” (Segerstrom, Stanton, Alden, & Shortridge, 2003, p. 909). 
Discrete forms of RT include worry, rumination, and depressive rumination, as well as 
reflecting, processing, and planning. Across forms, RT qualities are subsumed under 
three orthogonal dimensions: Valence (positive vs. negative content), Purpose (searching, 
uncertain, or questioning vs. solving, certain, or affirming), and Total RT (the total 
amount of RT across all forms) (Segerstrom et al., 2003, 2010).  
Among older adults, total RT has been found to be associated with higher IQ (r = 
0.26) and more perceived growth following trauma (Segerstrom, Roach, Evans, Schipper, 
& Darville, 2010; Segerstrom, Eisenlohr-Moul, Evans, & Ram, 2015). Although total RT 
was previously found to mediate the relationship between IQ and systemic inflammation, 
RT valence and RT purpose did not (Segerstrom et al., 2017). Further, in subsequent 
analyses, total RT significantly interacted with IQ, but RT valence and RT purpose did 
not.  
Despite these null findings, there is evidence that RT valence may have some 
health consequences. Negative RT has associated with maladaptive health outcomes, 
including higher depression and anxiety, poorer subjective health, lower number of 
natural killer cells, a higher cortisol awakening response, higher risk for coronary heart 
disease and angina pectoris, and higher resting blood pressure (Basevitz, Pushkar, 
Chaikelson, Conway, & Dalton, 2008; Chambers & Davidson, 2000; Harrington & 
Blankenship, 2002; Kubzansky et al., 1997; Segerstrom, Glover, Craske, Fahey, 1999; 
Segerstrom, Solomon, Kemeny, & Fahey, 1998; Segerstrom, Tsao, Alden, & Craske, 
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2000). Alternatively, some individuals engage in positive RT through which they can 
work through, make sense of, and integrate the experience into their beliefs about the 
world (Watkins, 2008). Positive RT has not been investigated as extensively as negative 
RT, but there is evidence to suggest that it may lead to more adaptive health outcomes. 
Positive RT has associated with more posttraumatic growth, as have cognitive rehearsal 
and processing 3 months later in cancer patients (Calhoun et al., 2000; Salsman, 
Segerstrom, Brechting, Carlson, & Andrykowski, 2009). Trait-level reflection has also 
predicted lower levels of IL-6 (Woody, Figueroa, Benencia, & Zoccola, 2016). Although 
RT valence did not moderate the relationship between IQ and systemic inflammation or 
interact with IQ in the study by Segerstrom and colleagues (2017), these findings suggest 
that further exploration of RT valence effects would be meaningful. 
The Present Study 
The purpose of this study was to replicate and extend the findings of Segerstrom 
and colleagues (2017). The first aim of this study was to test if the interaction between 
total RT and cognition (measured as IQ via the North American Adult Reading Test in 
Segerstrom et al., 2017 and as cognition via the Brief Test of Adult Cognition in the 
present study), predicts systemic inflammation, thus indicating that cognition moderates 
the RT-systemic inflammation relationship. The second aim included exploring whether 
RT valence interacts with cognition, indicating that cognition moderates the RT-systemic 
inflammation relationship. Lastly, any relationships that did not depend on cognition 
were tested in mediational models to see if cognition exists as a mechanism by which the 
relationship between RT and systemic inflammation exists. The study tested the 
following hypotheses: 
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1. Higher levels of cognition will be related to lower levels of an inflammatory 
marker composite. Bonferroni-adjusted post-hoc analyses tested correlations 
with each inflammatory marker. 
2. Individuals who engage in more total RT at lower levels of cognition will 
have lower levels of systemic inflammation, but lower levels of systemic 
inflammation are expected for individuals at higher levels of cognition 
regardless of the amount they engage in RT; thus, the relationship between RT 
and systemic inflammation will be moderated by cognition. Secondary, 
exploratory analyses included testing the same hypothesis with RT valence in 
place of total RT, such that individuals who engage in more positive RT at 
lower levels of cognition will have lower levels of systemic inflammation, but 
that those at higher levels of cognition will have lower levels of inflammation 
regardless of their RT valence. Bonferroni-adjusted post-hoc analyses were 
performed to investigate each inflammatory marker individually. 
3. If hypothesis 2 is not supported, total RT and RT valence were tested in a 
mediation model. In that case, the following was expected based on previous 
findings of Segerstrom and colleagues (2017): Individuals with higher levels 
of cognition will report more total RT and/or more positively valenced RT, 
which will be associated with lower systemic inflammation. Bonferroni-
adjusted post-hoc analyses were performed to investigate each inflammatory 
marker individually. 
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CHAPTER TWO: METHODS 
Participants 
The participants for the proposed study were drawn from de-identified 
participants of the Midlife in the United States (MIDUS) Refresher Project, collected 
between 2011 and 2014, which studies health and well-being in middle-aged adults. The 
MIDUS project was approved by the University of Wisconsin Institutional Review Board 
and follows national, local, and global regulations (Ryff et al., 2011-2014). Participants 
were selected by random digit dialing to landlines and cellphones to individuals who 
were noninstitutionalized, English-speaking adults in the United States (Ryff et al., 2011-
2014).  
Of the possible 3,577 participants who completed the initial MIDUS telephone 
interview and mail-in questionnaire, 225 participants completed the cognitive task over 
the phone, had IL-6, CRP, and TNF-a collected via blood draw, and completed the daily 
diary study, where they indicated at least one positive and one negative event during the 
8-day diary. In total, 40 participants were excluded based on the following criteria: 
current smokers of cigarettes, cigars, pipes, use of chewing tobacco or snuff; current 
chemotherapy or radiation treatment; current pregnancy; a diagnosis of tuberculosis, 
thyroid disease, AIDS/HIV, or lupus/autoimmune disease; or use of opioids. 
Additionally, 32 participants were excluded for use of the following drugs: 
immunosuppressant, systemic steroids, cytotoxic drugs, TNF-a blockers, or use of more 
than two of the following: a or b blockers or ACE inhibitors, hormone replacement, 
thyroid supplements, or antidepressants, anxiolytic, hypnotics, or antipsychotics. These 
exclusion criteria matched that of the original study (Segerstrom et al., 2017). 
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The final sample consisted of 153 adults, ranging in age from 25-70 years old (M = 
45.07, SD = 10.96). The participants were 50.3% female, 71.2% married, and 83% 
White/Caucasian. See Table 1 for full report of descriptive statistics. 
A power analysis was conducted using G*Power 3.1 to determine the minimum 
effect size that may be found given a sample size of N = 153, a-error probability = 0.05, 
and 80% power. The final sample would be sufficient to achieve 80% power to detect a 
small-to-moderate effect size of h2 = 0.049. Segerstrom and colleagues (2017) found a 
similar effect size, h2 = 0.056, in their moderation model that found that the interaction 
between IQ and total RT predicted IL-6; thus, the current sample should be able to 
sufficiently replicate the findings of the previous study. 
Table 1. Descriptive Statistics 
 Mean (SD) Minimum Maximum Skewness 
Gender (%) 
Female 
Male 
 
50.3 
49.7 
- - - 
Race (%) 
White 
Black/African American 
Native American/Alaska 
Native 
Asian 
Other 
 
83 
6.5 
1.3 
 
1.3 
7.8 
- - - 
Age 45.07 
(10.96) 25 70 .161 
Body Mass Index 28.83 
(7.57) 19.41 77.58 2.363 
Marital Status (%) 
Married 
Separated 
Divorced 
Widowed 
Never Married 
 
71.2 
1.3 
10.5 
3.3 
13.7 
- - - 
Biomarker Data Collection Site (%) 
UCLA 
UW 
Georgetown 
 
34 
31.4 
34.6 
- - - 
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Measures 
Measures were administered as part of a larger battery associated with the 
MIDUS Refresher Project. 
Demographics: Participants provided demographic information during an initial 
45-minute telephone interview and a 108-page mail questionnaire. Data were collected 
November 2011 – September 2014. Relevant demographic information includes age, 
gender, race/ethnicity, BMI, and marital status. 
Cognition: Cognition was assessed for 20 minutes over the phone with the Brief 
Test of Adult Cognition by Telephone (BTACT) following the completion of the initial 
telephone interview and mail questionnaire. Cognition data were collected between 
February 2012 – September 2014 (Lachman, 2011-2014). The BTACT includes seven 
facets: Word List Recall, Digit Span Backward, Category Fluency, Red/Green Task, 
Number Series, Backward Counting, and Short-Delay Word List Recall (Ryff & 
Lachman, 2011-2014; Lachman, Agrigoroaei, Tun, & Weaver, 2014). In prior study of 84 
healthy adults ranging from 23 to 80 years old, the BTACT had high internal consistency 
(a = 0.82). A factor analysis of the seven facets of the measure found that five of the 
seven tasks loaded onto executive functioning; factor loadings ranged from 0.30 to 0.88 
(Lachman, Agrigoroaei, Tun, & Weaver, 2014). For this reason, this measure is described 
as capturing “cognition” rather than “IQ” for this present study. The MIDUS Refresher 
project found an internal consistency of a = 0.71 in the sample that completed the 
cognitive assessment over the phone (Lachman, 2011-2014). 
IL-6, CRP, TNF-a: Biomarker data were collected during a 24-hour hospital stay 
at one of three sites (UCLA, University of Wisconsin, and Georgetown University) 
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between October 2012 and August 2016. Participants were eligible to participate in the 
biomarker project following completion of the initial telephone interview and mail 
questionnaire (Weinstein, Ryff, & Seeman, 2012-2016). IL-6, CRP and TNF-a were 
assessed via fasted blood draws on Day 2 of the 24-hour hospital stay. IL-6 was measured 
using the Quantikine High-sensitivity ELISA kit (assay range: 0.156-10 pg/mL; inter-
assay CV: 15.66%; intra-assay CV: 3.73%) at MIDUS BioCore Laboratory (University 
of Wisconsin, Madison, WI). TNF-a was measured by 
immunoelectrochemiluminescence using a V-plex Custom Human Cytokine Kit (assay 
range: 0.69-248 pg/mL; inter-assay CV: 7%; intra-assay CV: 3.19%) at MIDUS BioCore 
Laboratory (University of Wisconsin, Madison, WI). CRP was initially measured in 
plasma by a BNII nephelometer (assay range: 0.164-800 µg/mL; inter-assay CV: 1.08 - 
4.3%; intra-assay CV: 2.3 - 4.4%). Samples with very low levels of this biomarker were 
re-assayed using a high sensitivity assay (immunoelectrochemiluminescence). In the 
beginning of 2016, CRP plasma assays were all performed using the high-sensitivity 
assay. However, due to “technical difficulties” of assaying plasma in the 
immunoelectrochemiluminescence kits, CRP was eventually assayed in serum (assay 
range: 0.014-216 µg/mL; inter-assay CV: 4.72 – 5.16%; intra-assay CV: 2.2 – 4.1%; 
Blood, Urine, and Saliva Data Documentation, p. C5). Corrections and re-assay of this 
data were applied at the MIDUS BioCore Laboratory (University of Wisconsin, Madison, 
WI), where: CRP = 0.4906 * (serum MSD value) + 0.1743.  
Repetitive Thought: Repetitive thought data were collected as part of the MIDUS 
Refresher Daily Diary Project: National Study of Daily Experiences (NSDE) daily diary 
over the phone. The NSDE consisted of an 8-day study of self-reported daily experiences 
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and their effect on daily living, and 80.2% of daily diary participants completed all eight 
days. Data were collected October 2012 - November 2014. Participants were eligible to 
participate in the daily diary following completion of the initial telephone interview and 
mail questionnaire (Ryff & Almeida, 2012-2014). RT was assessed using the following 
questions and their follow-ups. First, participants either responded “yes” or “no” to the 
subsequent questions: 
Table 2. Negatively and positively valenced questions 
Negatively-Valenced Questions: Positively-Valenced Questions: 
Did you have an argument or a 
disagreement today? 
Did you have a positive interaction with 
someone today? 
Did you avoid a disagreement today? 
Did you have a positive experience at 
work? 
Did anything happen at work or school? 
Did you have a positive experience at 
home? 
Did anything happen at home? Did anything happen to a friend that was 
positive for you? 
Did any discrimination happen to you? Did anything else positive happen? 
Did anything happen to a friend that 
stressed you? 
 
Did anything else [negative] happen to 
you? 
 
The follow-up questions were not the same for the positively or negatively 
questions. If the participant responded “yes” to a positively-valenced questions, they 
were prompted with a follow-up question. For negative events, participants were asked 
two questions during each daily diary questionnaire. The following questions were used 
to quantify positive and negative RT: 
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Table 3. Negatively and positively valenced follow-up questions 
Negatively-Valenced Question Follow-up: Positively-Valenced Question Follow-up: 
How often have you thought about 
personal problems/ concerns? 
How much have you thought about this 
event? 
How often have you thought about 
situations that upset you? 
  
The negatively valenced questions were measured on a scale of 0 = “None of the 
time” to 4 = “All of the time,” and were strongly correlated (r = .699, p < .001). The 
positively valenced questions were measured on a scale of 0 = “Not at all” to 3 = “A lot”. 
The mean of the values across the week for each participant was used to define positive 
and negative RT. These values were standardized, and total RT was calculated as a sum 
of the standardized mean values of negative RT and positive RT per person across all 
diaries. RT valence was calculated as the difference of the standardized mean values of 
negative RT and positive RT. 
Data Analyses 
1. The composite score from the BTACT was correlated with an inflammation 
composite comprised of the mean of each participant’s standardized values of 
IL-6, CRP, and TNF-a. 
2. The systemic inflammation composite was individually regressed on the 
composite score from the BTACT (cognition) and total RT, centering each 
around their sample mean to ensure that zero was an interpretable value. Next, 
the systemic inflammation composite was regressed onto cognition and total 
RT in one model. Last, the hypothesis that cognition moderates the 
relationship between total RT and systemic inflammation was investigated by 
regressing the systemic inflammation composite variable on the interaction 
between cognition and total RT. Additionally, the secondary hypothesis that 
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cognition moderates the relationship between RT valence and systemic 
inflammation was investigated by regressing the systemic inflammation 
composite on the interaction between cognition and RT valence. Models were 
adjusted with centered age and BMI values, and statin use. Post-hoc analyses 
to investigate each biomarker individually were conducted by regressing each 
individual standardized inflammatory biomarker on the interaction between 
cognition and total RT and cognition and RT valence in three separate models. 
Lastly, the Bonferroni correction was implemented to control for Type I error.  
3. If cognition was found to not moderate the relationship between total RT or 
RT valence and systemic inflammation, total RT or RT valence were tested as 
mediators between cognition and systemic inflammation. Multiple regression 
analyses were performed using the composite score from the BTACT, the 
systemic inflammation composite, and the total RT or RT valence variables. 
Mediation was determined by the Sobel test and conducted through Preacher’s 
PROCESS in SPSS (Preacher & Hayes, 2004; Sobel, 1982). Post-hoc analyses 
to investigate each inflammatory biomarker individually was conducted by 
regressing each individual standardized biomarker on the mediational model 
of cognition and total RT and/or cognition and RT valence in two separate 
models. The Bonferroni correction was implemented to control for Type I 
error.
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CHAPTER THREE: RESULTS 
Descriptive Statistics 
Table 4 contains the descriptive statistics and correlations among study variables, 
with RT variables averaged within participants. Compared with the larger MIDUS 
Refresher sample, this study sample had a higher cognition (M = .509). Of the 153 
participants in the present study, 43 had at average or below-MIDUS-average cognition 
(M < 0.0). Compared to the overall sample from MIDUS that completed the daily diaries, 
the average amount of negative RT for this study sample was lower (M = -.199), but the 
average amount of positive RT was higher (M = .073); both were significantly different 
compared to the overall MIDUS sample (t = -3.201, p = .002). Although IL-6 and CRP 
were correlated (r = .633, p < .01), TNF-a was not significantly related to either 
biomarker (r = .138 and r = .141, respectively). Therefore, the Systemic Inflammation 
Composite was tested to satisfy planned analyses, but univariate analyses were also 
necessary. 
Table 4. Descriptive Statistics and Correlations of Study Variables (N = 153) 
 Mean (SD) 2 3 4 5 6 7 8 9 
1. Cognition 
2. Age 
.509 (.94) 
45.07 (10.96) 
-.213** 
 
-.039 
-.089 
-.137 
-.016 
-.125 
-.074 
.071 
-.051 
.022 
.037 
-.052 
.106 
-.161* 
.268** 
3. RT Total -.126 (1.0)   .006 - - -.046 -.083 -.069 
4. RT Valence -.273 (1.1)    - - -.015 .027 .042 
5. Neg RT -.120 (.74)     -.029 -.042 -.038 -.018 
6. Pos RT .073 (.73)      -.021 -.078 -.078 
Inflammation 
Composite 
       
  
7. TNF-aa .292 (.14)       .138 .141 
8. CRPa -.060 (.48)        .633** 
9. IL-6a .143 (.32)         
Note. a = log10 transformed values. * p < .05, ** p <.01 
 
Hypothesis 1 
Cognition was not significantly related to the systemic inflammation composite (r 
= -0.087, p = 0.285). Higher cognition was significantly related to lower levels of IL-6 (r 
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= -0.161, p =.046), but this relationship did not withstand Bonferroni correction (a = 
.05/4, or 0.0125). Higher IQ was not significantly related to levels of TNF-a or CRP (r = 
.022, p = .784; r = -0.052, p = .522).  
 
Hypothesis 2 
Neither interaction between cognition and Total RT or cognition and RT Valence 
significantly predicted systemic inflammation, as a composite, in the unadjusted model (β 
= -0.001, SE = .064, ∆R2 = .000; β = -0.154, SE = .052, ∆R2 = .022). Table 5 contains the 
results of the adjusted model, controlling for age, BMI, and statin use. Collectively, age, 
BMI, and statin use accounted for 25.2% of the variance in systemic inflammation 
(adjusted R2 = .252, Fchange = 18.114, p < .001). In the adjusted models, the interaction 
between cognition and RT Valence significantly accounted for 4.8% of the variance in 
predicting systemic inflammation (β = -0.230, ∆R2 = .048, Fchange = 10.241, p = .002), but 
the interaction between cognition and Total RT did not (β = .070, ∆R2 = .005, Fchange = 
.964, p = .328). 
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Table 5. Adjusted Multiple Regression for Models Predicting Systemic Inflammation 
Composite Variable 
Post-hoc analyses were conducted to investigate whether cognition moderated the 
relationship between the RT variables and the individual inflammatory biomarkers. In the 
unadjusted models, the interaction between Total RT and cognition did not significantly 
predict levels of TNF-a (β = .013), IL-6 (β = -0.019), or CRP (β = .004). Further, the 
interaction between RT Valence and cognition did not significantly predict TNF-a (β = -
0.078) or IL-6 (β = -0.082). However, for those with higher levels of cognition, more 
positive RT was related to lower levels of CRP (β = -0.179, ∆R2 = .03, Fchange = 4.636, p = 
.033). In the adjusted models, age, BMI, and statin use accounted for 4.3% of the 
variance in TNF-a (adjusted R2 = .043, Fchange = 3.254, p = .023), 25.1% of the variance 
in IL-6 (adjusted R2 = .251, Fchange = 17.984, p < .001), and 17.5% of the variance in CRP 
(adjusted R2 = .175, Fchange = 11.743, p < .001). The interaction between cognition and 
Total RT did not significantly predict levels of TNF-a (β = .055, ∆R2 = .003, Fchange = 
 Model 1 Model 2 Model 3 Model 4 
 B(SE) β B(SE) β B(SE) β B(SE) β 
Total RT         
Age .013(.005) .188* .013(.005) .192* .012(.057) .186* .012(.005) .186* 
BMI .045(.007) .468 .045(.007) .470 .045(.007) .468 .046(.007) .478 
Statin Use -.284 (.152) -.139 -.286(.152) -.140 -.278(.153) -.136 -.294(.154) -.144 
IQ   .014 (.057) .018 .012(.057) .015 .016(.057) .020 
Total     -.030(.051) -.042 -.030(.051) -.042 
IQxTotal       .056(.057) .070 
∆R2 .267 .000 .002 .005 
F Change 18.114 .061 .340 .964 
RT Valence         
Age .013(.005) .188* .013(.005) .192* .013(.005) .190* .015(.005) .221 
BMI .045(.007) .468 .045(.007) .470 .046(.007) .477 .048(.007) .498 
Statin Use -.284 (.152) -.139 -.286(.152) -.140 -.295(.153) -.144 -.297(.148) -.146 
IQ   .014 (.057) .018 .009(.057) .011 .038(.056) .049 
Valence     -.037(.050) -.053 -.071(.050) -.102 
IQxValence       -.144(.045) -.230 
∆R2 .267 .000 .003 .048 
F Change 18.114 .061 .531 10.241 
Note. Bolded results, p < .01; * p < .05 
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.453), IL-6 (β = .035, ∆R2 = .001, Fchange = .234), or CRP (β = .065, ∆R2 = .004, Fchange = 
.747). However, those with higher levels of cognition, and who engaged in more positive 
RT, had significantly lower levels of systemic IL-6 (β = -0.161, ∆R2 = .024, Fchange = 
4.867, p = .029) and CRP (β = -0.240, ∆R2 = .052, Fchange = 10.097, p = .002) but not 
TNF-a (β = -0.103, ∆R2 = .010, Fchange = 1.531, p = .218). See Appendix 1 for a full report 
of the adjusted models. 
In the fully adjusted model, for individuals with higher than average cognition (1 
SD above the mean), more positive RT was significantly associated with lower systemic 
inflammation (β = -0.31, p = .004). For individuals with lower than average cognition (1 
SD below the mean), more positive RT was not associated with differences in systemic 
inflammation (β = .106, p = .21). Similar, significant simple main effects were obtained 
for CRP (β = -0.306, p = .007 vs. β = .128, p = .16; see Figure 1); similar but not 
statistically significant simple main effects were obtained for IL-6 (β = -.210, p = .054 vs. 
β = 0.081, p = .35; see Figure 2). As expected, there were not significant simple main 
effects of RT valence at either level of IQ on TNF-a (β = -0.164, p = .188 vs. β = .023, p 
= .819). 
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Figure 1. Simple Main Effect of CRP. Standardized log10 CRP for individuals 1 SD 
below and 1 SD above the cognition mean as predicted by more negative RT (-1 SD RT 
valence) and high (+1 SD RT valence). Model estimates are shown with their standard 
errors. CRP = C-reactive protein; RT = repetitive thought. 
 
 
 20 
 
Figure 2. Simple Main Effect of IL-6. Standardized log10 IL-6 for individuals 1 SD below 
and 1 SD above the cognition mean as predicted by more negative RT (-1 SD RT 
valence) and high (+1 SD RT valence). Model estimates are shown with their standard 
errors. CRP = Interleukin-6; RT = repetitive thought. 
 
Hypothesis 3 
Total RT was tested as a mediator of the relationship between cognition and the 
systemic inflammation composite as well as each individual inflammatory biomarker 
because prior analyses revealed that these outcome variables did not depend on the 
interaction between cognition and total RT. Barron and Kenny’s (1996) criteria were 
used to determine if mediation occurred. However, in both the non-adjusted and adjusted 
models, cognition was not correlated with total RT (r = -0.039, p = .629; r = .147, p = 
 21 
.516), therefore, criteria for mediation were not met for models including cognition, total 
RT and the systemic inflammation composite, TNF-a, IL-6, or CRP.  
Additionally, RT valence was tested as a mediator of the relationship between 
cognition and TNF-a, however, in both the unadjusted and adjusted models, cognition 
was not related to RT valence and therefore criteria for mediation were not met (r = .137, 
p = .091; r = .211, p = .148) 
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CHAPTER FOUR: DISCUSSION 
Driven by the established relationship between cognition and systemic 
inflammation, this study aimed to replicate previous findings by Segerstrom, Reed, and 
Scott (2017) in a larger, and more diverse sample of adults. Additionally, this studied 
aimed to extend the previous findings by looking at an additional facet of RT, valence, 
and additional biomarkers, CRP and TNF-a. Consistent with Segerstrom and colleagues 
(2017), individuals with higher cognition had lower levels of IL-6 but not the other 
biomarkers or the systemic inflammation composite. Further, although cognition 
consistently moderated the relationship between RT valence and systemic inflammation, 
it did not moderate effects of RT total and systemic inflammation. There was a 
significant simple main effect of cognition suggesting that individuals with higher levels 
of cognition, and whose thought content is more positive, have lower levels of 
biomarkers that are common prognostic indicators for chronic, systemic inflammation 
and, in later life, inflammaging. 
Unlike the previous study, total RT did not interact with cognition in a way that 
significantly predicted systemic inflammation. However, the previous findings were 
extended in that IL-6 and CRP were predicted by the interaction between cognition and 
RT valence, even after controlling for age, BMI, and statin use. There was minimal 
overlap in the age range of this study (range= 25-70) compared to the previous study 
(range = 60-93), suggesting that RT may serve different purposes at different stages in 
life; in older adults, the facet of RT important for better health outcomes, may not be 
whether or not an individual has more positive thoughts, but instead that engage in more 
thinking overall. Additionally, the discrepancy in findings may be due to 
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measuring/capturing IQ and cognition with different measures, which can be a common 
problem in replication work (Open Science Collaboration, 2015).  
The BTACT includes measures that load heavily onto executive function (EF), 
including Digit Span Backward, Category Fluency, Red/Green Task, Number Series, 
Backward Counting (Ryff & Lachman, 2011-2014; Lachman, Agrigoroaei, Tun, & 
Weaver, 2014), suggesting that the BTACT may capture executive functioning and fluid 
intelligence more precisely than generalized intelligence or IQ. Previous literature 
suggests that fluid intelligence is closely related to EF and that poorer EF may be related 
to any individual’s propensity to engage in more negative RT (Blair & Spreen, 1989; 
Segerstrom et al., 2010). Alternatively, Segerstrom and colleagues (2017) used the North 
American Adult Reading Test to capture IQ, which reflects crystallized intelligence, 
rather than fluid intelligence or EF. It may be that two cognitive processing are 
functioning simultaneously: valence of thought content may be interacting with EF and 
fluid intelligence versus total RT interacting with crystallized intelligence to separately 
effect circulating levels of systemic inflammation. However, correlations in this study 
between cognition and RT valence were small and not statistically significant (r = -0.137, 
p = .091). 
Segerstrom and colleagues (2017) suggested that older adults with an IQ = 103, 
may benefit from engaging in more RT to protect themselves from future health 
outcomes related to higher systemic inflammation. Alternatively, this study found a 
simple main effect of cognition that suggests that individuals with a higher cognitive 
capacity (+1 SD) had lower levels of systemic inflammation if they engaged in more 
positive RT. The findings from both studies suggest there are benefits of more positive 
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RT for individuals functioning at a higher level of cognition and more total RT for 
individuals functioning at an average level of cognition (based on the IQ mean in the 
previous sample). This may be related to other positive health behaviors and subsequent 
outcomes experienced by individuals with higher levels of cognition or because 
individuals with higher levels of cognition have a better capacity with which to self-
regulate themselves (Hofmann, Schmeichel, & Baddeley, 2012; Scheier & Carver, 1987). 
Treatment or simple self-regulatory skills involving cognitive restructuring or “thinking 
positively” may be beneficial for individuals with a higher than average level of 
cognition in helping to work against inflammaging before its onset. On the other hand, 
these findings may not be generalizable to the half of the general population who function 
at average to lower-than-average levels of cognition. Future research should investigate 
the role the RT may have in effecting levels of systemic inflammation, and thus aging 
and other health outcomes, as it relates to lower levels of cognitive functioning. 
This study was not without limitations. Whereas Segerstrom and colleagues 
(2017) collected data longitudinally, the MIDUS dataset provides single timepoint 
collections of all survey, cognitive, and biomarker data. Additional data points could 
have provided more reliable measures of biomarkers and cognition over time. Further, a 
more precise measurement of IQ through MIDUS would have provided a closer 
comparison between results. Although the NSDE asked “How much have you thought 
about this event” following each question about positive events, this was not mirrored 
following questions about negative events. A more direct comparison between reactions 
to positive and negative events may have allowed for RT to be captured more precisely. 
Lastly, despite a possible N = 3,577, there were only 153 adults who completed the 
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MIDUS survey, cognitive test, National Study of Daily Experiences, and physiological 
data collection that met our inclusion criteria. A larger N would have allowed for findings 
with more power. 
Future research in this area should investigate the relationship between EF, fluid 
intelligence, and RT valence to better understand how one’s mental abilities affect one’s 
propensity to think positively about their world and potentially experience better future 
health effects. Additionally, findings in this area could help influence future treatment or 
skills for those who worry or ruminate to the point of dysfunction or impairment. Lastly, 
the third facet of RT, purpose, should be investigated to assess the role it may play in 
protecting against poor future health outcomes.  
Overall, this study provides evidence to suggest that a more positively-focused 
content of RT in middle age may lead to lower levels of systemic inflammation in 
individuals with a higher level of cognition. In turn, this effect may help protect against 
future negative effects that chronic, systemic inflammation has on the aging immune 
system and overall functioning. 
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Appendix. Adjusted Multiple Regression for Moderation Models Predicting Individual 
Biomarker Variables  
Model 1 Model 2 Model 3 Model 4 
TNF-a B(SE) Β B(SE) β B(SE) β B(SE) β 
Total RT 
Age .008(.008) .087 .009(.008) .100 .009(.008) .098 .009(.008) .097 
BMI .022(.011) .164* .023(.011) .171* .023(.011) .171* .024(.011) .178* 
Statin Use -.549(.234) -.197* -.556(.235) -.199* -.552(.237) -.198* -.568(.238) -.204* 
Cognition .066(.087) .062 .064(.088) .061 .069(.088) .064 
Total -.016(.079) -.016 -.016(.079) -.016 
CogxTotal .059(.088) .055 
∆R2 .061 .004 .000 .003 
F Change 3.254* .564 .040 .453 
RT Valence 
Age .008(.008) .087 .009(.008) .100 .009(.008) .098 .010(.008) .112 
BMI .022(.011) .164* .023(.011) .171* .024(.011) .178* .025(.011) .187* 
Statin Use -.549(.234) -.197* -.556(.235) -.199* -.567(.236) -.203* -.569(.236) -.204* 
Cognition .066(.087) .062 .059(.088) .056 .077(.089) .073 
Valence -.046(.077) -.048 -.067(.079) -.071 
CogxValence -.089(.072) -.103 
∆R2 .061 .004 .002 .010 
F Change 3.254* .564 .351 1.531 
Model 1 Model 2 Model 3 Model 4 
IL-6 B(SE) β B(SE) β B(SE) β B(SE) β 
Total RT 
Age .022(.007) .240 .021(.007) .229 .021(.007) .225 .021(.007) .225 
BMI .058(.009) .442 .057(.009) .435 .057(.009) .434 .058(.010) .439 
Statin Use -.120(.207) -.043 -.115(.208) -.041 -.108(.209) -.039 -.119(.211) -.042 
Cognition -.053(.077) -.050 -.055(.078) -.052 -.053(.078) -.049 
Total -.026(.070) -.026 -.026(.070) -.026 
CogxTotal .038(.078) .035 
∆R2 .266 .002 .001 .001 
F Change 17.984 .476 .135 .234 
RT Valence 
Age .022(.007) .240 .021(.007) .229 .021(.007) .228 .023(.007) .250 
BMI .058(.009) .442 .057(.009) .435 .058(.010) .439 .060(.009) .453 
Statin Use -.120(.207) -.043 -.115 .208 -.122(.209) -.044 -.124(.206) -.044 
Cognition -.053(.077) -.050 -.057(.078) -.054 -.029(.078) -.027 
Valence -.028(.068) -.030 -.061(.069) -.065 
CogxValence -.138(.063) -.161* 
∆R2 .266 .002 .001 .024 
F Change 17.984 .476 .170 4.867* 
Model 1 Model 2 Model 3 Model 4 
CRP B(SE) β B(SE) β B(SE) β B(SE) β 
Total RT 
Age .008(.007) .087 .008(.007) .093 .008(.007) .086 .008(.007) .086 
BMI .056(.010) .423 .056(.010) .426 .056(.010) .424 .057(.010) .433 
Statin Use -.184(.218) -.066 -.187(.218) -.067 -.175(.220) -.063 -.194(.221) -.070 
Cognition .030(.081) .028 .026(.082) .024 .031(.082) .029 
Total -.048(.073) -.049 -.048(.073) -.049 
CogxTotal .070(.082) .065 
∆R2 .191 .001 .002 .004 
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Note. Bolded results, p < .01; * p < .05; Cog = Cognition 
  
F Change 11.743 .132 .428 .747 
RT Valence         
Age .008(.007) .087 .008(.007) .093 .008(.007) .092 .011(.007) .124 
BMI .056(.010) .423 .056(.010) .426 .057(.010) .431 .060(.010) .453 
Statin Use -.184(.218) -.066 -.187(.218) -.067 -.196(.220) -.070 -.199(.213) -.071 
Cognition   .030(.081) .028 .024(.082) .023 .067(.081) .062 
Valence     -.035(.072) -.037 -.084(.072) -.089 
CogxValence       -.206(.065) -.240 
∆R2 .191 .001 .001 .052 
F Change 11.743 .132 .243 10.097 
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